Loading...

Michael Campbell, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentSurgery
Address2340 Sutter Street
San Francisco CA 94115
Phone415-885-3710
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Crane CA, Austgen K, Haberthur K, Hofmann C, Moyes KW, Avanesyan L, Fong L, Campbell M, Cooper S, Oakes SA, Parsa AT, Lanier LL. Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. Proc Natl Acad Sci U S A. 2014 Sep 2; 111(35):12823-8. PMID: 25136121; PMCID: PMC4156766.
    2. Campbell M, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013; 8(10):e79114. PMID: 24205370; PMCID: PMC3812150.
    3. Adisa CA, Eleweke N, Alfred AA, Campbell M, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ. Biology of breast cancer in Nigerian women: a pilot study. Ann Afr Med. 2012 Jul-Sep; 11(3):169-75. PMID: 22684136.
      View in: PubMed
    4. Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell M, Esserman LJ. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer. Ann Surg Oncol. 2012 Nov; 19(12):3979-86. PMID: 22622474.
      View in: PubMed
    5. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell M, Esserman LJ. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011 Nov; 130(2):635-44. PMID: 21717106.
      View in: PubMed
    6. Mukhtar RA, Nseyo O, Campbell M, Esserman LJ. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn. 2011 Jan; 11(1):91-100. PMID: 21171924.
      View in: PubMed
    7. Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(1):137-44. PMID: 19728082; PMCID: PMC4087110.
    8. Ryan CJ, Zavodovskaya M, Youngren JF, Campbell M, Diamond M, Jones J, Shiry L, Allan G, Maddux BA, Goldfine ID. Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells. Prostate. 2008 Aug 1; 68(11):1232-40. PMID: 18491370.
      View in: PubMed
    9. Zavodovskaya M, Campbell M, Maddux BA, Shiry L, Allan G, Hodges L, Kushner P, Kerner JA, Youngren JF, Goldfine ID. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. J Cell Biochem. 2008 Feb 1; 103(2):624-35. PMID: 17562544.
      View in: PubMed
    10. Campbell M, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. Breast cancer growth prevention by statins. Cancer Res. 2006 Sep 1; 66(17):8707-14. PMID: 16951186.
      View in: PubMed
    11. Jabrane-Ferrat N, Campbell M, Esserman LJ, Peterlin BM. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice. Cancer Gene Ther. 2006 Nov; 13(11):1002-10. PMID: 16841083.
      View in: PubMed
    12. Kumar AS, Campbell M, Benz CC, Esserman LJ. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. J Clin Oncol. 2006 May 1; 24(13):2127; author reply 2127-8. PMID: 16648516.
      View in: PubMed
    13. Gable KL, Maddux BA, Penaranda C, Zavodovskaya M, Campbell M, Lobo M, Robinson L, Schow S, Kerner JA, Goldfine ID, Youngren JF. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther. 2006 Apr; 5(4):1079-86. PMID: 16648580.
      View in: PubMed
    14. Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat. 2005 Nov; 94(1):37-46. PMID: 16142439.
      View in: PubMed
    15. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell M. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res. 2005 Jul; 19(7):649-51. PMID: 16161030.
      View in: PubMed
    16. Campbell M, Scott J, Maecker HT, Park JW, Esserman LJ. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat. 2005 May; 91(2):163-71. PMID: 15868444.
      View in: PubMed
    17. Kim SW, Chao TH, Xiang R, Lo JF, Campbell M, Fearns C, Lee JD. Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells. Cancer Res. 2004 Nov 1; 64(21):7732-9. PMID: 15520177.
      View in: PubMed
    18. Shoemaker M, Cohen I, Campbell M. Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol. 2004 Aug; 93(2-3):381-4. PMID: 15234781.
      View in: PubMed
    19. Campbell M, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res. 2002 Nov-Dec; 22(6C):3843-52. PMID: 12553004.
      View in: PubMed
    20. Campbell M, Wollish WS, Lobo M, Esserman LJ. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev Biol Anim. 2002 Jun; 38(6):326-33. PMID: 12513120.
      View in: PubMed
    21. Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G. Ductal growth is impeded in mammary glands of C-neu transgenic mice. Oncogene. 2000 Dec 7; 19(52):5982-7. PMID: 11146549.
      View in: PubMed
    22. Borden EC, Esserman L, Linder DJ, Campbell M, Fulton AM. Biological therapies for breast carcinoma: concepts for improvement in survival. Semin Oncol. 1999 Aug; 26(4 Suppl 12):28-40. PMID: 10482192.
      View in: PubMed
    23. Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM, Campbell M. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice. Cancer Immunol Immunother. 1999 Feb; 47(6):337-42. PMID: 10203064.
      View in: PubMed
    24. Hsu FJ, Kwak L, Campbell M, Liles T, Czerwinski D, Hart S, Syrengelas A, Miller R, Levy R. Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann N Y Acad Sci. 1993 Aug 12; 690:385-7. PMID: 8368764.
      View in: PubMed
    25. Kwak LW, Campbell M, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med. 1992 Oct 22; 327(17):1209-15. PMID: 1406793.
      View in: PubMed
    26. Kwak LW, Campbell M, Levy R. Tumor resistance induced by syngeneic bone marrow transplantation and enhanced by interleukin 2: a model for the graft versus leukemia reaction. Cancer Res. 1992 Aug 1; 52(15):4117-20. PMID: 1638524.
      View in: PubMed
    27. Clayberger C, Luna-Fineman S, Lee JE, Pillai A, Campbell M, Levy R, Krensky AM. Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med. 1992 Feb 1; 175(2):371-6. PMID: 1732410; PMCID: PMC2119105.
    28. Campbell M, Zelenetz AD, Levy S, Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992 Feb; 29(2):193-203. PMID: 1542297.
      View in: PubMed
    29. Kwak LW, Campbell M, Zelenetz AD, Levy R. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy. Blood. 1991 Nov 15; 78(10):2768-72. PMID: 1824269.
      View in: PubMed
    30. Bahler DW, Campbell M, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood. 1991 Sep 15; 78(6):1561-8. PMID: 1909196.
      View in: PubMed
    31. Zelenetz AD, Campbell M, Bahler DW, Takahashi S, Oren R, Esserman L, Umetsu DT, Kwak LW, Maloney DG, Brown S. Follicular lymphoma: a model of lymphoid tumor progression in man. Ann Oncol. 1991 Feb; 2 Suppl 2:115-22. PMID: 2049308.
      View in: PubMed
    32. Kwak LW, Campbell M, Levy R. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model. Cancer Detect Prev. 1991; 15(4):323-5. PMID: 1794139.
      View in: PubMed
    33. Kwak LW, Campbell M, Zelenetz AD, Levy R. Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin. Blood. 1990 Dec 1; 76(11):2411-7. PMID: 2257310.
      View in: PubMed
    34. Campbell M, Esserman L, Byars NE, Allison AC, Levy R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol. 1990 Aug 1; 145(3):1029-36. PMID: 2373859.
      View in: PubMed
    35. Berinstein N, Campbell M, Lam K, Carswell C, Levy S, Levy R. Idiotypic variation in a human B lymphoma cell line. J Immunol. 1990 Jan 15; 144(2):752-8. PMID: 2295809.
      View in: PubMed
    36. Levy S, Campbell M, Levy R. Functional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line. J Exp Med. 1989 Jul 1; 170(1):1-13. PMID: 2501443; PMCID: PMC2189373.
    37. Campbell M, Esserman L, Byars NE, Allison AC, Levy R. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor. Int Rev Immunol. 1989; 4(4):251-70. PMID: 2519929.
      View in: PubMed
    38. Campbell M, Esserman L, Levy R. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide. J Immunol. 1988 Nov 1; 141(9):3227-33. PMID: 3049819.
      View in: PubMed
    39. Basham TY, Race ER, Campbell M, Reid TR, Levy R, Merigan TC. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action. J Immunol. 1988 Oct 15; 141(8):2855-60. PMID: 2971732.
      View in: PubMed
    40. Starnes CO, Carroll WL, Campbell M, Houston LL, Apell G, Levy R. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants. J Immunol. 1988 Jul 1; 141(1):333-9. PMID: 3132505.
      View in: PubMed
    41. Campbell M, Carroll W, Kon S, Thielemans K, Rothbard JB, Levy S, Levy R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J Immunol. 1987 Oct 15; 139(8):2825-33. PMID: 3498771.
      View in: PubMed
    42. Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood. 1987 Jan; 69(1):199-210. PMID: 2431729.
      View in: PubMed
    43. Campbell M, Bieber M, Levy R, Teng NN. Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies. J Immunol. 1986 Apr 15; 136(8):2983-8. PMID: 3485677.
      View in: PubMed
    44. Kaminski MS, Kitamura K, Maloney DG, Campbell M, Levy R. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol. 1986 Feb 1; 136(3):1123-30. PMID: 3484499.
      View in: PubMed
    Michael's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP